Aukett Associates PLC
15 January 2001
Aukett Associates PLC ('Aukett' or the 'Company')
Director's Shareholding and Additional Listing
Additional Listing
Options over 62,708 ordinary shares in the Company were exercised by John
Thake, a director of the Aukett, under the Company's Executive Share Option
Schemes on 12 January 2001, at an exercise price of 5.103p per share.
In addition, further options over 145,545 ordinary shares were subscribed by
employees of the Company, details as follows:
7,839 options exercised at 7p on 02.01.01
15,676 options exercised at 5.103p on 02.01.01
47,030 options exercised at 5.103p on 07.01.01
75,000 options exercised at 3.25p on 07.01.01
Application has been made to the London Stock Exchange and the UK Listing
Authority for 208,253 new ordinary shares, which rank pari passu with existing
ordinary shares, to be admitted to the Official List. It is expected that
admission will become effective and dealings will commence on 18 January 2001.
Director's Shareholding
Following this exercise of options and listing, Mr Thake is now interested in
1,570,726 ordinary shares in Aukett, which represents 2.17% of the Company's
issued ordinary share capital.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.